New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 1, 2024 - Teva launched an AB-rated generic version of Novartis’ Sandostatin LAR Depot (octreotide) intramuscular injection.
Download PDF
Return to publications
